苯二氮䓬类药物对心脏骤停后患者苏醒时间的影响
本研究为回顾性单中心研究,纳入2010年1月至2019年9月期间收治的院内外心脏骤停后昏迷患者,排除6小时内苏醒、创伤或神经事件所致骤停、不可存活的原始脑损伤及难治性休克者。主要暴露为骤停后72小时内高剂量苯二氮䓬(>10 mg咪达唑仑等效剂量/天),主要结局为苏醒时间。2778例患者中621例符合标准,209例(34%)苏醒,中位苏醒时间4天(IQR 3-7)。高剂量苯二氮䓬组苏醒时间晚于未使用组(5天 vs 3天,P=0.004),校正后HR 0.63(95%CI 0.43-0.92)。结论认为高剂量苯二氮䓬暴露与心脏骤停后昏迷幸存者苏醒延迟独立相关。
要点
- 心脏骤停后72小时内使用高剂量苯二氮䓬(>10 mg咪达唑仑等效剂量/天)与苏醒延迟独立相关(校正HR 0.63,95%CI 0.43-0.92)。
- 高剂量苯二氮䓬组中位苏醒时间5天(IQR 3-11),未使用组3天(IQR 3-6),P=0.004。
- 两组住院时间、苏醒至出院时间及机械通气时间相似。
- 研究为回顾性单中心设计,621例符合标准,209例(34%)苏醒。
适用人群与场景
- 纳入:2010年1月至2019年9月期间收治的院内外心脏骤停后昏迷患者。
- 排除:骤停后6小时内苏醒者、创伤或神经事件所致骤停者、不可存活的原始脑损伤者、难治性休克者。
研究设计与关键结果
- 研究类型:回顾性单中心研究;研究期间共2778例患者,621例符合纳入标准,其中209例(34%)苏醒。
- 主要暴露:骤停后72小时内高剂量苯二氮䓬(>10 mg咪达唑仑等效剂量/天)使用;主要结局:苏醒时间。
- 高剂量苯二氮䓬组苏醒时间晚于未使用组:5天(IQR 3-11) vs 3天(IQR 3-6),P=0.004。
- 校正回归分析显示高剂量苯二氮䓬暴露与苏醒延迟独立相关:校正HR 0.63(95%CI 0.43-0.92)。
- 住院时间、苏醒至出院时间及机械通气时间两组相似。
证据类型、等级与局限
- 证据类型:回顾性单中心研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为高剂量苯二氮䓬暴露与心脏骤停后昏迷幸存者苏醒延迟独立相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: Although guidelines recommend use of short acting sedation after cardiac arrest, there is significant practice variation. We examined whether benzodiazepine use is associated with delayed awakening in this population.
METHODS: We performed a retrospective single center study including comatose patients treated after in- or out-of-hospital cardiac arrest from January 2010 to September 2019. We excluded patients who awakened within 6 h of arrest, those who arrested due to trauma or neurological event, those with nonsurvivable primary brain injury and those with refractory shock. Our primary exposure of interest was high-dose benzodiazepine (>10 mg of midazolam equivalents per day) administration in the first 72-h post arrest. Our primary outcome was time to awakening. We used Cox regression to test for an independent association between exposure and outcome after controlling for biologically plausible covariates.
RESULTS: Overall, 2778 patients presented during the study period, 621 met inclusion criteria and 209 (34%) awakened after a median of 4 [IQR 3-7] days. Patients who received high-dose benzodiazepines awakened later than those who did not (5 [IQR 3-11] vs. 3 [IQR 3-6] days, P = 0.004). In adjusted regression, high-dose benzodiazepine exposure was independently associated with delayed awakening (adjusted hazard ratio 0.63 (95% CI 0.43-0.92)). Length of stay, awakening to discharge, and duration of mechanical ventilation were similar across groups.
CONCLUSION: High-dose benzodiazepine exposure is independently associated with delayed awakening in comatose survivors of cardiac arrest.
参考来源
- Levito MN, McGinnis CB, Groetzinger LM, et al. Impact of benzodiazepines on time to awakening in post cardiac arrest patients. Resuscitation. 2021. PMID: 34102268. doi:10.1016/j.resuscitation.2021.05.026
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。